簡介:SAR191801 抑制劑是一種hPGDS抑制劑, 熒光偏振檢測或EIA法測得IC50值為12 nM。
SAR191801 抑制劑物理化學(xué)性質(zhì):
分子式 |
C22H20N6O3 |
分子量 |
416.433 |
精確質(zhì)量 |
416.16 |
PSA |
126.92 |
LogP |
3.1369 |
SAR191801 抑制劑詳細介紹:
中文名稱: |
SAR191801 抑制劑 |
中文別名: |
N-[[3-[5-(1-羥基-1-甲基乙基)-1,2,4-惡二唑-3-基]苯基]甲基]-2-(2-吡啶基)-5-嘧啶甲酰胺 |
英文名稱: |
SAR191801 |
英文別名: |
SAR191801;hPGDS-IN-1 |
CAS號: |
1234708-04-3 |
分子式: |
C22H20N6O3 |
分子量: |
416.43 |
詳細描述: |
博飛美科提供1234708-04-3,SAR191801 抑制劑,SAR191801,Perfemiker,上?,F(xiàn)貨。 Medlife,致力于提供高品質(zhì)、高性價比小分子化合物的產(chǎn)品。 Medlife小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 hPGDS抑制劑。hPGDS-IN-1是一種hPGDS抑制劑, 熒光偏振檢測或EIA法測得IC50值為12 nM。 查詢關(guān)鍵詞:“1234708-04-3,SAR191801 抑制劑,SAR191801,PC16813,Perfemiker,上?,F(xiàn)貨”。 |
SAR191801 抑制劑參考文獻:
[1]. Vandeusen, Christopher L, et al. Phenyloxadiazole derivatives as PGD inhibitors and their preparation, pharmaceutical compositions and use in the treatment of allergic and inflammatory disorders. From PCT Int. Appl. (2011), WO 2011044307 A1 20110414.
[2]. Hahn Chang S. Method for treating macular degeneration using syk multikinase inhibitor, an hPGDS inhibitor and a DP antagonist. From PCT Int. Appl. (2010), WO 2010080563 A2 20100715.
[3]. Weiberth Franz J, et al. Demonstration on Pilot-Plant Scale of the Utility of 1,5,7-Triazabicyclo[4.4.0]dec-5-ene (TBD) as a Catalyst in the Efficient Amidation of an Unactivated Methyl Ester. From Organic Process Research & Development (2012), 16(12), 19